Health & Medicine

STAT+: Pharmalittle: We're reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more

31 sec read100 views0 listens

Novo Nordisk appointed Mars CEO Poul Weihrauch as a board observer to bolster its U.S. obesity market strategy, signaling a push towards strengthening consumer focus and expertise. This move is crucial for tech professionals in health tech, highlighting the industry's shift towards consumer-centric approaches in drug delivery and marketing. The FDA also approved Kresladi, a gene therapy for LAD-1, which, despite its limited patient pool, underscores the regulatory body’s evolving stance on manufacturing requirements for rare disease treatments.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

100

U.S. teen withdraws lawsuit against Meta over social media addiction

A U.S. teenager has withdrawn his lawsuit against Meta, ending a high-profile case examining the mental health impacts of social media on children before it went to trial. This decision follows recent settlements and legal actions against Meta over c...

Ali Nemati

AI & Machine LearningApr 930 sec read

AI-Powered Drug Marketer Medvi Responds After Allegations About Fake Doctors and Patients

Medvi, an AI-powered drug marketing company, issued a response to allegations of unethical practices including fake doctors and deepfake patient images. The company's founder claims the issues were addressed after public backlash but fails to fully c...

Ali Nemati

Health & MedicineMar 3126 sec read

STAT+: Over-the-top psychedelic promos could undermine the field's drug development efforts

Marketing agencies are producing YouTube videos for psychedelic drug developers like Helus Pharma and AtaiBeckley, making bold claims about their investigational drugs' efficacy. Such over-the-top promotions could erode trust among regulators and est...

Ali Nemati

Health & MedicineMar 1228 sec read

STAT+: The FDA is targeting telehealth marketing of GLP-1 drugs. Who's prescribing them?

The FDA is targeting telehealth companies for misleading marketing of compounded GLP-1 weight loss drugs, warning them against implying FDA approval. The crackdown also implicates affiliated medical groups that prescribe these unapproved medications,...

Ali Nemati

Tech & GadgetsFeb 2527 sec read

How Mexico's 'CJNG' Drug Cartel Embraced AI, Drones, and Social Media

The leader of Mexico's CJNG drug cartel is reportedly deceased, yet the organization continues to leverage advanced technologies like AI, drones, and social media to maintain its operations. This adaptation underscores how modern tech tools are being...

Ali Nemati

STAT+: Pharmalittle: We're reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more

Related Articles

U.S. teen withdraws lawsuit against Meta over social media addiction

AI-Powered Drug Marketer Medvi Responds After Allegations About Fake Doctors and Patients

STAT+: Over-the-top psychedelic promos could undermine the field's drug development efforts

STAT+: The FDA is targeting telehealth marketing of GLP-1 drugs. Who's prescribing them?

How Mexico's 'CJNG' Drug Cartel Embraced AI, Drones, and Social Media